2021 Massachusetts General Laws
Part I - Administration of the Government
Title XXII - Corporations
Chapter 176g - Health Maintenance Organizations
Section 4hh - Coverage for Long-Term Antibiotic Therapy for Lyme Disease; Experimental Drugs
[ Text of section added by 2021, 29, Sec. 26 effective July 1, 2021 until July 1, 2022. See 2021, 29, Sec. 69.]
Section 4HH. (a) For the purposes of this section, "Long-term antibiotic therapy'' and "Lyme disease'' shall have the meaning ascribed to them in section 12DD of chapter 112.
(b) An individual or group health maintenance contract shall provide coverage for long-term antibiotic therapy for a patient with Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient's symptoms, diagnostic test results or response to treatment. An experimental drug shall be covered as a long-term antibiotic therapy if it is approved for an indication by the United States Food and Drug Administration; provided, however, that a drug, including an experimental drug, shall be covered for an off-label use in the treatment of Lyme disease if the drug has been approved by the United States Food and Drug Administration.
